JSPR Jasper Therapeutics, Inc.

NASDAQ
$0.60

Jasper Therapeutics, Inc. (JSPR) is expected to report earnings on November 9, 2026, during market hours. The consensus earnings estimate is a loss of $0.08 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -31.4% since its last earnings release on August 14, 2026.

Jasper Therapeutics Beat Consensus Estimates
Friday, August 14, 2026 · 11:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 11:00 AM ET
Earnings Whisper
-
vs ($0.08)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.68

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Jasper Therapeutics, Inc.

Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.